# Prakash Gowd

> Prakash Gowd is a seed investor at Toronto Innovation Acceleration Partners backing Biopharma. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Toronto Innovation Acceleration Partners](https://shizune.co/investors/profile/mars-innovation-mi)
- Location: Toronto, Canada
- Total investments: 1
- Last investment: Sep 2024
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/prakashgowd/?originalSubdomain=ca
- Website: https://tiap.ca/team/prakash-gowd/

Prakash Gowd is a seed investor at Toronto Innovation Acceleration Partners in Toronto focused on Biopharma and Life Science. Prakash Gowd is based out of Toronto, Ontario and is the Vice President of TIAP - Toronto Innovation Acceleration Partners and also serves as Board Member for Appili Therapeutics. Prakash previously worked at Novamind as Chief Operating Officer & Head of Corporate Development. Prakash Gowd attended the McGill University. Prakash Gowd has beencertified Chartered Director (C.Dir.).

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HDAX Therapeutics | HDAX Therapeutics is pioneering next-gen precision therapeutics for cardiovascular and neurological diseases by targeting their root causes to enhance patient outcomes. | $3.2M | Seed | Sep 05, 2024 |  |

1 of 1 investments shown.

## Co-investors
- [FACIT](https://shizune.co/investors/profile/facit-prospects-oncology-fund) — VC Fund, 2 deals together
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund, 1 deal together
- [Eos BioInnovation](https://shizune.co/investors/profile/eos-bioinnovation) — VC Fund, 1 deal together
- [Ontario Centre of Innovation](https://shizune.co/investors/profile/oci-e51e) — VC Fund, 1 deal together
- [Ontario Bioscience Industry Organization](https://shizune.co/investors/profile/ontario-bioscience-industry-organization) — VC Fund, 1 deal together
- [SeedFolio](https://shizune.co/investors/profile/seedfolio) — VC Fund, 1 deal together

## About Toronto Innovation Acceleration Partners

VC Fund · Toronto, Canada

MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.

5 contacts available at Toronto Innovation Acceleration Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Ben Rogers | Director | https://shizune.co/investors/profile/ben-rogers-4 |
| Dominic Jaikaran | Director | https://shizune.co/investors/profile/dominic-jaikaran |
| Mark Zdziebko | Manager | https://shizune.co/investors/profile/mark-zdziebko |
| Prakash Gowd | Vice President | https://shizune.co/investors/profile/prakash-gowd-841b |
| Susanne Staer | Manager | https://shizune.co/investors/profile/susanne-staer |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Prakash Gowd invest in?

Prakash Gowd invests primarily in Biopharma, Life Science and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Prakash Gowd last invest?

The most recent investment recorded for Prakash Gowd closed in Sep 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co